TABLE OF CONTENTS FIGURES AND TABLES PART 1. INTRODUCTION · Report description · Objectives of the study · Market segment · Years considered for the report · Currency · Key target audience PART 2. METHODOLOGY PART 3. EXECUTIVE SUMMARY PART 4. MARKET OVERVIEW · Introduction · Drivers · Restraints · Impact of COVID-19 pandemic PART 5. MARKET BREAKDOWN BY TYPE · Albumin · Creatine kinase-MB (CK-MB) · Low-density lipoproteins (LDL) and high-density lipoproteins (HDL) · Myoglobin · Natriuretic peptides - B-type natriuretic peptide (BNP) & N-terminal pro b-type natriuretic peptide (NT-proBNP) · Troponins · Others PART 6. MARKET BREAKDOWN BY LOCATION OF TESTING · Laboratory testing · Point of care testing PART 7. MARKET BREAKDOWN BY APPLICATION · Acute coronary syndrome · Atherosclerosis · Congestive heart failure · Myocardial infarction · Others PART 8. MARKET BREAKDOWN BY REGION · North America · Asia Pacific · Europe · Rest of the World (ROW) PART 9. KEY COMPANIES · Abbott Laboratories · ACS Biomarker B.V. · bioMerieux SA · Bio-Rad Laboratories, Inc. · Danaher Corporation · F. Hoffmann-La Roche AG · Johnson & Johnson · Novartis AG · QuidelOrtho Corporation · Randox Laboratories Ltd. · Siemens AG · Thermo Fisher Scientific Inc. · Tosoh Bioscience, Inc. *REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES DISCLAIMER